I think Mo's comment about "not to worry" about the use cases for the chip, is probably coming from a place where we've seen other companies spruik their technology for an application which has never eventuated. This can have the outcome of eroding the trust of investors. With my limited understanding I can only speculate, but on that basis, it probably hasn't ever been crystal clear about what the tech CAN be used for because any hurdles along the way could have deviated the tech design in various pathways of complications, leading it to be better suited to one application vs another.
Saying that "we don't know exactly what will be the best application because....." would trigger too many concerns on the market.
I think Mo just tried to navigate a "dammed if you do, dammed if you don't" communication, in short, between the lines, not yet confident enough to know what it'll be first targeted as used for, but, don't worry, we have confidence there'll be a marketable application.
- Forums
- ASX - By Stock
- Ann: Biochip experiments begin to develop kidney disease testing
I think Mo's comment about "not to worry" about the use cases...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AXE (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.5¢ |
Change
0.025(9.62%) |
Mkt cap ! $72.63M |
Open | High | Low | Value | Volume |
26.0¢ | 28.5¢ | 26.0¢ | $115.5K | 427.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3634 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 16324 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3634 | 0.275 |
2 | 8702 | 0.270 |
2 | 46952 | 0.265 |
5 | 40138 | 0.260 |
1 | 19607 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 16324 | 2 |
0.290 | 53509 | 4 |
0.295 | 23264 | 2 |
0.300 | 70542 | 8 |
0.305 | 10000 | 1 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
AXE (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online